Example：10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
What Is Driving the Epidemiology of Methicillin-Resistant Staphylococcus aureus Infections in Europe? Microbial Drug Resistance (IF3.431), Pub Date : 2021-07-16, DOI: 10.1089/mdr.2020.0259 Michael A. Borg, Liberato Camilleri
Introduction: The burden from infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the European Union/European Economic Area (EU/EEA) has increased in recent years, especially in the higher prevalence southern and eastern countries. Addressing this challenge requires a clear knowledge of the factors driving this epidemiology to inform effective national interventions and campaigns.